copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include . . . Because of the risk of exacerbating psychosis, patients with a major psychotic disorder should not be treated with CREXONT In addition, medications that antagonize the effects of dopamine used to treat psychosis may exacerbate the symptoms of Parkinson’s disease and may decrease the effectiveness of CREXONT [see Drug Interactions (7 2)]
FDA Label for Crexont Capsule, Extended Release Oral - Indications . . . There is an increased risk for hallucinations in patients taking CREXONT In Study 1, 17 589 (3%) of CREXONT-treated patients reported hallucinations compared to 2 630 (0 3%) of oral immediate-release carbidopa-levodopa-treated patients
CREXONT - Amneal Pharmaceuticals LLC There is an increased risk for hallucinations in patients taking CREXONT In Study 1, 17 589 (3%) of CREXONT-treated patients reported hallucinations compared to 2 630 (0 3%) of oral immediate-release carbidopa-levodopa-treated patients
Crexont (carbidopa and levodopa) for Parkinson’s disease Treatment with Crexont may lead to hallucinations (seeing or hearing things that are not real), psychosis, and impulse control issues, including gambling, overeating, and increased sexual urges
Crexont 70 mg-280 mg capsule, extended release - Kaiser Permanente Tell your doctor right away if you have any serious side effects, including: mental mood changes (such as confusion, agitation, hallucinations) unusual strong urges (such as increased gambling, increased sexual urges) signs of infection (such as sore throat that doesn't go away, fever, chills) vision changes (such as blurred double decreased